Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3187 Ly-395153 Allosteric modulator of AMPA receptors
DCC3188 Ly444711 Orally active ghrelin agonist, bindjng with high affinity to and being a potent activator of the growth hormone secretagogue receptor 1a (GHS-R1a) receptor
DCC3189 Ly451646 AMPA receptor potentiator
DCC3190 Ly456236 Hydrochloride Selective mGlu1 receptor antagonist
DCC3191 Ly-465608 Novel potent and selective dual PPARalpha/gamma agonist
DCC3192 Ly-466195 Novel competitive GLUK5 receptor antagonist
DCC3193 Ly544344 Prodrug of LY354740, highly selective and potent agonist of group II mGlu receptors (mGluR2)
DCC3194 Ly-580276 Novel inhibitor of the type I transforming growth factor beta receptor (TβRI)
DCC3195 Lyc-31138 Novel F1F0-ATPase modulator, significantly decreasing M2 glutamate and increasing M4 glutamate
DCC3196 Ly-hn2am Nove fluorescent probe for highly sensitive monitoring drug induced lysosomal pH value changes, exhibiting good biological compatibility, low cytotoxicity and high resistance to photobleaching
DCC3197 Lyngbyastatin 7 Natural Potent Marine-Derived Elastase Inhibitor
DCC3198 Lysine Orotate Inhibitor of viral replication, especially useful in the treatment of the Herpes family of viruses which includes Herpes Simplex 1 and 2 , EBV , CMV and Varicella.
DCC3199 Lyso-7 Inhibitor of cyclooxygenase (COX); Pan partial agonist of PPARγ, PPARα and PPARβ/δ
DCC3200 Lzz-02 Novel inhibitor of the transcriptional activity of β-catenin, degrading the expression of β-catenin by stabilizing axin 2 and diminishing downstream proteins levels, including c-Myc and cyclin D1, effectively shrinking tumor xenograft derived from colonic
DCC3201 M-084 Hydrochloride TRPC4/5 channel blocker, exhibiting antidepressant and anxiolytic effects
DCC3202 M1-pam-a Novel selective muscarinic M1 receptor positive allosteric modulator, significantly improved scopolamine-induced cognitive deficits without prominent signs of diarrhea at up to 1000 mg/kg in mice
DCC3203 M1-pam-b Novel selective muscarinic M1 receptor positive allosteric modulator, showed both significant improvement of scopolamine-induced cognitive deficits and severe diarrhea
DCC3204 M4k2009 Featured M4K2209 is a potent, selective BMP type I receptor ALK2 inhibitor with IC50 of 9 nM, >180-fold selective over ALK5 (IC50=2427 nM).
DCC3205 M4k2127 Novel potent and selective ALK2 inhibitor, showing high initial brain uptake, including in the region of interest (pons)
DCC3206 M4k2163 Novel CNS Penetrant ALK2 Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma
DCC3207 M-5mpep Partial antagonist of mGlu5
DCC3208 M7594_0037 Novel Peptide Deformylase (PDF) Inhibitor, having inhibitory activity against HeLa, A549 and MCF-7
DCC3209 Mac-0547630 Novel potent and selective inhibitor of UppS without off-target effects on membrane potential
DCC3210 Mac13243 Novel inhibitor of the bacterial lipoprotein targeting chaperone, LolA
DCC3211 Macluraxanthone Natural immunomodulator, significantly decreasing TNF-α and IL-10 cytokine production, regulating the NF-κB and MAPK signaling pathways, displaying the strongest antiproliferative effects with IC50 values of 2.84 and 0.95 μM against A431 and HeLa cancer c
DCC3212 Madtp-372 Potent and selective inhibitor of the induction of cytopathic effect by CHIKV and VEEV
DCC3213 Madurmycin Polyether ionophore antibiotic, inhibiting proliferation and induces apoptosis in myoblast cells
DCC3214 Magl-2102 Novel reversible monoacylglycerol lipase (MAGL) inhibitor
DCC3215 Magnesium L-threonate Inhibitor of TNF-α, preventing and restoring memory deficits associated with neuropathic pain
DCC3216 Magnesium Oxaloacetate Inhibitor of the amebicidal activity of activated murine macrophages, helping the parasite to survive within the mouse large intestine and increasing the survival of C. elegans exposed to H2O2

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X
>